About this trial
In light of the ongoing controversy surrounding the efficacy of bupivacaine liposomes, our study was designed to investigate, for the first time, the differential postoperative analgesic effects between bupivacaine liposomes combined with bupivacaine hydrochloride and bupivacaine hydrochloride alone in transverse thoracic muscle plane block treatment. The aim is to provide evidence-based medical guidance for drug selection in regional block local anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-90 years;
ASA Class I ~ III;
Patients undergoing elective median sternotomy.
Disqualifiers
Emergency surgery;
Re-operation;
Coagulation dysfunction;
Preoperative left ventricular function was poor (ejection fraction <35%);
Trial design
Parallel
Treatments tested in this trial
Transverse thoracic muscle plane block (TTMPB) using liposomal bupivacaine and bupivacaine mixture
Procedure/SurgeryLiposomal bupivacaine and bupivacaine mixture were used for transverse thoracic muscle plane block (TTMPB) in experimental group.
Transverse thoracic muscle plane block (TTMPB) using bupivacaine hydrochloride
Procedure/SurgeryBupivacaine hydrochloride was used for transverse thoracic muscle plane block (TTMPB) in active control group.
Treatment groups
Trial outcomes
Primary outcomes
Third-day opioid consumption
Opioid consumption was converted to Milligram morphine equivalent (MME) using the analgesic Drug Equivalence calculator.
Secondary outcomes
Cumulative opioid consumption 72 hours after surgery
Opioid consumption was converted to Milligram morphine equivalent (MME) using the analgesic Drug Equivalence calculator.
Numerical rating scales, NRS
Numerical rating scales, NRS: 0-10 A score of 0 is reported as completely painless, and a score of 10 is reported as the most intolerable pain.
Sensory block resolution time
Time of resolution of numbness in the sternum skin.
Consumption of acetaminophen
Acetaminophen requirement after surgery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.